Long-acting injectable ART superior to standard care for poorly adherent people with HIV

by Elana GotkineFor people with HIV (PWH) and a history of suboptimal adherence to antiretroviral therapy, long-acting injectable treatment with cabotegravir and rilpivirine (LAI) is superior to oral

Updated on: March 20,2024 13

Long-acting injectable ART superior to standard care for poorly adherent people with HIV

by Elana GotkineFor people with HIV (PWH) and a history of suboptimal adherence to antiretroviral therapy, long-acting injectable treatment with cabotegravir and rilpivirine (LAI) is superior to oral

Updated on:March 20,2024 13

Study finds COVID-19 had greater impact on life expectancy than previously believed

by Institute for Health Metrics and EvaluationCredit: Unsplash/CC0 Public DomainA newstudypublished inThe Lancetreveals never-before-seen details about staggeringly high m

Updated on: March 20,2024 12

Study finds COVID-19 had greater impact on life expectancy than previously believed

by Institute for Health Metrics and EvaluationCredit: Unsplash/CC0 Public DomainA newstudypublished inThe Lancetreveals never-before-seen details about staggeringly high m

Updated on:March 20,2024 12

Why you shouldn't be afraid to start running after middle age

by Alister Hart, The ConversationCredit: Pixabay/CC0 Public DomainAs someone who started marathon running in midlife, I know how many aches and pains (and doubts) you can have if you take on the chall

Updated on: May 14,2024 0

Why you shouldn't be afraid to start running after middle age

by Alister Hart, The ConversationCredit: Pixabay/CC0 Public DomainAs someone who started marathon running in midlife, I know how many aches and pains (and doubts) you can have if you take on the chall

Updated on:May 14,2024 0

COVID-19 vaccination shown to protect people with blood cancer

by Ludwig Maximilian University of MunichStudy time chart, anti-spike IgG levels and IgG avidity in individuals with hematologic neoplasia and in healthy individuals at different time points afte

Updated on: April 12,2024 13

COVID-19 vaccination shown to protect people with blood cancer

by Ludwig Maximilian University of MunichStudy time chart, anti-spike IgG levels and IgG avidity in individuals with hematologic neoplasia and in healthy individuals at different time points afte

Updated on:April 12,2024 13

The Cure for HIV | Scripps News Reports

Updated on: August 26,2024 0

The Cure for HIV | Scripps News Reports

Updated on:August 26,2024 0

Babies infected with syphilis are part of a growing tragedy—one that could be easily prevented

Babies infected with syphilis are part of a growing tragedy—one that could be easily preventedby Skye McGregor, Belinda Hengel and Robert Monaghan,The ConversationCredit: CC0 Public DomainData&n

Updated on: August 28,2024 0

Babies infected with syphilis are part of a growing tragedy—one that could be easily prevented

Babies infected with syphilis are part of a growing tragedy—one that could be easily preventedby Skye McGregor, Belinda Hengel and Robert Monaghan,The ConversationCredit: CC0 Public DomainData&n

Updated on:August 28,2024 0

New study highlights COVID-19's adaptive strategy for infection

byUniversity of Minnesota Medical SchoolCryo-EM analyses of residue 417 in regulating the conformation of recombinant SARS-CoV-2 spike ectodomain. Prototypic SARS-CoV-2 spike ectodomains contain

Updated on: January 26,2024 13

New study highlights COVID-19's adaptive strategy for infection

byUniversity of Minnesota Medical SchoolCryo-EM analyses of residue 417 in regulating the conformation of recombinant SARS-CoV-2 spike ectodomain. Prototypic SARS-CoV-2 spike ectodomains contain

Updated on:January 26,2024 13

COVID-19 vaccine responses to be studied in people with immune deficits

by NIH/National Institute of Allergy and Infectious DiseasesZebra-print ribbon, a symbol for awareness of primary immunodeficiencies and other rare diseases. Credit: NIAIDA study assessing how pe

Updated on: April 12,2024 19

COVID-19 vaccine responses to be studied in people with immune deficits

by NIH/National Institute of Allergy and Infectious DiseasesZebra-print ribbon, a symbol for awareness of primary immunodeficiencies and other rare diseases. Credit: NIAIDA study assessing how pe

Updated on:April 12,2024 19

Discovery identifies those likely to experience life-threatening dengue fever

by Monash UniversityStudy cohort characteristics. Individuals with a confirmed secondaryDENVinfection were recruited for the study at the onset of fever and followed up for progressio

Updated on: March 13,2024 16

Discovery identifies those likely to experience life-threatening dengue fever

by Monash UniversityStudy cohort characteristics. Individuals with a confirmed secondaryDENVinfection were recruited for the study at the onset of fever and followed up for progressio

Updated on:March 13,2024 16

Study explores characteristics associated with poor COVID-19 antibody response

by Melissa Rohman,Northwestern UniversityAnti-S1 IgG levels over time between first vaccine dose and serosurvey by socio-demographic and clinical correlates. Plot of predicted anti-S1 antibody l

Updated on: March 27,2024 0

Study explores characteristics associated with poor COVID-19 antibody response

by Melissa Rohman,Northwestern UniversityAnti-S1 IgG levels over time between first vaccine dose and serosurvey by socio-demographic and clinical correlates. Plot of predicted anti-S1 antibody l

Updated on:March 27,2024 0

First-in-human vaccine trial for deadly Nipah virus launched

JANUARY 11, 2024byUniversity of OxfordCredit: CC0 Public DomainThe University of Oxford has launched a new clinical trial to test a vaccine to protect people against deadly Nipah virus.This is t

Updated on: March 25,2024 4

First-in-human vaccine trial for deadly Nipah virus launched

JANUARY 11, 2024byUniversity of OxfordCredit: CC0 Public DomainThe University of Oxford has launched a new clinical trial to test a vaccine to protect people against deadly Nipah virus.This is t

Updated on:March 25,2024 4

How does SARS-CoV-2 evade our immune defenses?

by John Hewitt , Medical XpressColorized scanning electron micrograph of a cell (blue) heavily infected with SARS-CoV-2 virus particles (red), isolated from a patient sample. Image captured at the NIA

Updated on: April 22,2024 20

How does SARS-CoV-2 evade our immune defenses?

by John Hewitt , Medical XpressColorized scanning electron micrograph of a cell (blue) heavily infected with SARS-CoV-2 virus particles (red), isolated from a patient sample. Image captured at the NIA

Updated on:April 22,2024 20